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Small Non-Coding RNAs: New 
insights in Modulation of Host 
immune Response by intracellular 
Bacterial Pathogens
Waqas Ahmed, Ke Zheng and Zheng-Fei Liu*
State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 
China
Pathogenic bacteria possess intricate regulatory networks that temporally control the 
production of virulence factors and enable the bacteria to survive and proliferate within 
host cell. Small non-coding RNAs (sRNAs) have been identified as important regulators 
of gene expression in diverse biological contexts. Recent research has shown bacterial 
sRNAs involved in growth and development, cell proliferation, differentiation, metabolism, 
cell signaling, and immune response through regulating protein–protein interactions or 
via their ability to base pair with RNA and DNA. In this review, we provide a brief overview 
of mechanism of action employed by immune-related sRNAs, their known functions in 
immunity, and how they can be integrated into regulatory circuits that govern virulence, 
which will facilitate our understanding of pathogenesis and the development of novel, 
more effective therapeutic approaches to treat infections caused by intracellular bacterial 
pathogens.
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iNTRODUCTiON
Precise control of gene expression is an essential feature of the immune system. The immune system 
depends on a sophisticated gene expression program equipped with an arsenal of strategies to fight 
against infections, mainly controlled by well-described transcriptional and posttranscriptional 
mechanisms (1). Cells of the immune system are able to undergo dramatic changes in transcription 
mechanisms to efficiently organize expression of genes critical to defense. Innate and adaptive immune 
cell differentiation and activation depends largely on these transcription events (2). Neutrophils, 
macrophages, and dendritic cells (DCs) exhibit both common and unique sets of toll-like receptors 
(TLRs), chemokines, and cytokines in innate immune responses. microRNAs (miRNA) and RNA-
binding proteins determine the specific region of the gene accessible to transcription factors that 
ultimately regulate transcription (1).
Small non-coding RNAs (sRNAs) play critical roles in bacterial gene expression and are recog-
nized as key regulators in bacteria. Typically, these RNA regulators range from 50 to 200 nt in length 
and act on independently expressed targets, often encoded in the intergenic region (3, 4). sRNA 
controls bacterial gene expression by employing multiple molecular strategies to regulate the expres-
sion of gene targets, including binding directly to complementary sequences present in target mRNA 
molecules (5, 6). sRNAs interact with their specific target to exert both positive and negative effects 
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on gene expression. In positive regulation, sRNAs bind with 
target mRNA at the 5′-untranslated region (UTR) and alter the 
secondary structure of the mRNA, to access a ribosome-binding 
site (RBS) that allows translation (7, 8). In addition, sRNA can 
bind to the 3′-UTR of target mRNA, ultimately increasing gene 
expression and stabilizing the transcript (9). Alternatively, sRNAs 
can also exert inhibitory effects by binding with mRNA 5′-UTR, 
resulting in decreased stability, degradation of the mRNA, occlu-
sion of the RBS, and inhibition of translation (10). sRNAs are 
widely identified and their number constantly growing due to 
their involvement in diverse biological contexts including cell 
proliferation, development, differentiation, apoptosis, metabo-
lism, stress response and signal transduction (11, 12).
Pathogenic bacteria have to face hostile and changing environ-
ments characterized by high concentrations of reactive oxygen 
and nitrogen species, low pH, and limited nutrient availability 
that hinder in their replication and infection to succeed (13). 
Pathogens have evolved a variety of strategies to survive and 
replicate within eukaryotic cells, establishing mechanisms to 
manipulate the host-cell machinery for their own benefit (14). 
After internalization in host cells, pathogenic bacteria modulate 
their trafficking to avoid lysosomal fusion by occupying a special-
ized membrane-bound vesicle. Intracellular bacteria are divided 
in two classes: vacuolar intracellular bacteria, such as Salmonella, 
Mycobacterium, Legionella, Brucella, and Coxiella, that survive 
and replicate either by avoiding vacuole–lysosome fusion or 
by altering the phagolysosome environment; and cytosolic 
intracellular bacteria, including Francisella, Shigella, Listeria, 
Burkholderia, and Rickettsia, that usually escape to proliferate 
within the cytosol of host cell (15, 16).
Recent developments in biocomputation have revealed a large 
number of regulatory sRNAs and have highlighted their potential 
links to bacterial pathogenesis (17, 18). Bacterial adaptation to 
intracellular environment niches is efficiently regulated in both 
time and space. These newly identified sRNAs play an integral 
part in virulence expression and bacterial stress responses that 
are ultimately advantageous for pathogens in adaptation and 
modification of the host-immune response (19). Understanding 
the mechanisms adopted by sRNAs to control immune cell 
function and how immune-related cells maintain cell viability 
and competitiveness in varying environmental niches is critical. 
However, roles of sRNA regulators in pathogenesis and immune 
response mechanisms have only begun to be investigated. In this 
review, we summarize the mechanisms employed by bacterial 
sRNAs in gene regulation and sRNA-based strategies to counter 
host immune response mechanisms as well as their implications 
in the pathogenesis of intracellular bacteria.
MeCHANiSMS eMPLOYeD BY 
BACTeRiAL sRNAs FOR GeNe 
ReGULATiON
Bacterial regulatory sRNAs operate at all layers of gene regula-
tion to modulate translation, transcription, DNA maintenance 
or silencing, and mRNA stability. They use different mechanisms 
to achieve these outstanding regulatory functions (5). The major 
mechanisms employed by bacterial sRNAs for gene regulation are 
as follows:
 (i) Trans-encoded sRNA are usually encoded on the genome in 
trans location distinct from their targets and share partial 
complementarity with their target mRNAs. They potentially 
establish base pairing to the Shine-Dalgarno (SD) sequence 
of target mRNAs usually 10–25  nt in length to sequester 
the RBS (4). Additionally, trans-acting sRNAs are firmly 
coupled with the RNases activity to exploit their regulatory 
functions resulting in RNA turnover through RNA cleav-
age (20). In many cases, it is thought that trans-encoded 
RNA molecules engage RNA chaperone Hfq to facilitate 
sRNA-mediated regulation due to limited complementarity 
between sRNAs and their mRNA targets (21).
 (ii) Cis-encoded sRNAs are another class of intracellular bacte-
rial sRNAs complementary to their target encoded in the 
same region of DNA. They have functional ability to interact 
autonomously as they are transcribed from DNA strand 
opposite to genes they regulate (22). Cis-encoded sRNAs 
vary greatly in size and usually located in the UTRs of the 
corresponding gene to establish firm RNA duplex forma-
tion which in turn affects ribosome-binding/translation 
and rearranges the secondary structures to affect mRNA 
stability or termination events as shown in Figure 1 (23).
 (iii) In addition to RNA–RNA regulation characterized by base 
pairing, sRNA can also interact with regulatory proteins 
to directly modify their activities by mimicking and, thus, 
efficiently compete with DNA or RNA targets. The best 
suited example for such interaction is CsrA/RsmA family 
regulators (global carbon storage regulator). All Csr/Rsm-
regulatory networks represent a common feature in patho-
genic bacteria, the two-component system (TCS) regulate 
the transcription of the small RNAs to sequester CsrA. The 
sRNAs directly bind with CsrA/RsmA to sequester it from 
interacting with mRNA targets usually in close immediate 
vicinity of the RBS. This phenomena result in the enhancing 
the translation of the previously blocked transcripts (24).
 (iv) Recent studies indicates that a class of sRNAs participates in 
an adaptive microbial immune system known as clustered 
regularly interspaced short palindromic repeats (CRISPR), 
which provide the bacteria with RNA-based acquired 
immunity against invading DNA elements, such as from 
bacteriophages, plasmids, and mobile genetic elements 
(25). This system is composed of an array of conserved 
short DNA repeat sequences originating from foreign DNA 
and interspaced by variable spacer regions. Furthermore, 
together with the conserved Cas proteins, the crRNA can 
recognize the complementary DNA target to mediate its 
degradation (26).
sRNAs AS COORDiNATORS OF 
PATHOGeNeSiS
After internalization in the host cell, intracellular bacterial 
pathogens are challenged by diverse changing environmental 
FiGURe 1 | Simplified representation of mechanisms by which sRNAs function in bacteria. (A) The trans-encoded sRNAs interact with their specific target 
through imperfect base pairing which ultimately results in both positive and negative effect in altering gene expression to promote RNase degradation of the 
double-stranded RNA molecules. (B) The cis-encoded sRNAs share extensive complementarity by binding with target mRNA resulting in transcriptional termination, 
degradation of the sRNA–target RNA complex, and affecting translation through a putative loop formation and, consequently, the cessation of the RNA polymerase 
activity. (C) The dimeric RNA-binding protein CsrA interacts with target mRNA, typically represented in a hairpin loop structure, transcription termination, leading to 
an alteration of the accessibility of the translation machinery, and/or the stability of the RNA. (D) Mechanism of action of CRISPR arrays for transcription full length 
RNA which directly target the foreign DNA via CAS proteins resulting in subsequent degradation of the exogenous DNA.
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conditions. Host cells have established mechanisms to counteract 
the intracellular bacteria, including degradation of pathogens 
within the lysosomal compartments. Conversely, as successful 
pathogens, intracellular bacteria have acquired strategies to avoid 
lysosomal degradation, such as the arrest or delay of vacuolar 
maturation in Salmonella (late endosome) and Mycobacterium 
(early endosome), control of intracellular trafficking in Brucella 
and Legionella, and resistance to lysosome action in Coxiella (27, 
28). These pathogens have developed strategies to evade host 
protective mechanisms for adaptation, survival, replication, and 
persistence within host cells to establish chronic infection that is 
mainly dictated by the presence of certain structural components 
and virulence factors (29, 30).
The Csr-type system is the most common posttranscriptional 
regulatory network in intracellular bacteria and is well-character-
ized in Legionella and Salmonella. Legionella uses effector proteins 
to modulate host-cell function and establish a replicative niche by 
forming a membrane-bound vacuole designated the Legionella-
containing vacuole (LCV) (31). These effector proteins are under 
the control of CsrA, which participates in the type IVB secretion 
system (T4SS) to modulate endoplasmic reticulum (ER)–Golgi 
vesicular trafficking, with involvement of sRNA-binding protein 
in survival and replication of intracellular pathogens (32). The 
VipA, RalF, and YlfA effector proteins have been linked directly 
to vesicular trafficking to alter the host-cell activity (33). The 
CsrA controls expression of virulence regulatory genes near 
the Shine-Dalgarno (SD) sequence of target mRNA located 
on Salmonella pathogenicity islands (SPIs). Also the transition 
from a sessile to a motile life form of Salmonella enterica serovar 
Typhimurium is strongly affected by CsrA (34). In S. enterica 
serovar Typhimurium, CsrA seems to act positively on swarm-
ing motility, and it is required for accurate flagella expression 
by stabilizing the flhDC and the fliA mRNAs, which are the 
regulators of the flagella operon. This stabilizing effect leads to 
an increased production of flagellar proteins (34). In Legionella, 
CsrA also affects the flagella sigma factor FliA, but in contrast 
to S. enterica serovar Typhimurium, overexpression of CsrA in 
Legionella pneumophila resulted in lower fliA transcription and 
subsequently to reduced levels of FlaA, the major structural flagel-
lar protein controlled by FliA (35). Although CsrA is apparently a 
common regulator for flagella expression in different bacteria, the 
regulatory function differs significantly between them, as it can 
be either positive or negative (36, 37). sRNAs, such as RsmY and 
RsmZ, regulate the expression of effector protein RsmA to affect 
the replication of Legionella in macrophages (38), and directly 
target T4SS regulatory genes to facilitate intracellular survival of 
pathogen (39, 40).
The RfrA and RfrB are two RybB homologous sRNAs in 
Salmonella enterica that play an essential role in the intracellular 
replication in macrophages. Additionally, Fur, a well-known 
repressor of RybB sRNA is also required for phagocytosis and 
intracellular survival of Salmonella in human macrophages 
(Figure 2) (41). These conserved sRNAs regulate expression of 
virulence genes involved in the oxidative stress, iron homeostasis, 
and acid resistance within host cells. Furthermore, they have 
been induced in THP-1 macrophages, fibroblasts, and murine 
FiGURe 2 | implication of RNA-mediated regulation in pathogenesis of intracellular bacteria. (A) The regulatory cascade of Salmonella is composed of 
sRNAs, RfrA and RfrB, plays vital role in the establishment of Salmonella-containing vacuole (SCV), which facilitates adoption of pathogen within host cell resulting in 
regulation of iron homeostasis, oxidative stress, and acid resistance. (B) The regulatory sRNAs, RsmY and RsmZ, control the action of effectors secreted in cytosol 
of host which helps in establishing the Legionella-containing vacuole (LCV). (C) The regulatory sRNAs, AbcR1 and AbcR2, interact with hfq to modulate the 
virulence and intracellular survival of Brucella.
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macrophages, suggesting a complementary role of sRNAs in 
intracellular replication (42). Caswell et  al. (43) reported two 
homologous sRNA in Brucella, named AbcR1 and AbcR2, that 
play significant role in pathogenicity and establishment of chronic 
infection. Deletion of AbcR1 or AbcR2 alone in Brucella did not 
affect intracellular growth in macrophages, but deletion of both 
resulted in its significant attenuation in macrophages, as well as 
in mouse model of chronic Brucella infection (43).
Transcriptional regulators are the subject of considerable 
study at the molecular level, and the number of newly discovered 
sRNAs is increasing, with more than 100 identified in Salmonella 
(19). In many cases, the ubiquitous RNA-binding protein, Hfq, 
establishes dynamic interactions with RNA molecules to function 
in virulence of intracellular pathogens. Due to limited comple-
mentarity between sRNA and target mRNA, Hfq is essential to 
facilitate RNA–RNA interactions. Indeed, deletion of hfq has dra-
matic impact on virulence and intracellular survival in Brucella 
abortus (44), L. pneumophila (45), and Salmonella typhimurium 
(46). In addition, Hfq-bound sRNAs are directly involved in 
regulating metabolic systems and gene expression such as that 
required for two-component regulatory systems, lipopolysac-
charide biosynthesis, host-cell invasion, fatty acid metabolism, 
central carbon metabolism, and in motility of bacteria (47, 48).
The sRNA GcvBs regulate the ABC transport system through 
direct binding with extended C/A-rich regions at the mRNA 
level resulting in lower expression and inhibition of the ABC 
transport system in S. typhimurium (49). Furthermore, IsrJ 
sRNA-dependent temporal regulation has been reported in SPIs 
affecting pathogen invasion of intestinal epithelial cells (50).
IsrM is the SPI-encoding sRNA involved in direct regulation 
of HilE and SopA virulence genes, which are key regulators of 
Salmonella virulence and essential for bacteria to evade the host 
immune system. Specifically, Salmonella hinders production of 
HilE and SopA for invasion of epithelial cells, which facilitates its 
survival within the host macrophage (51).
AmgR, a cis-encoded 1.2 kb long antisense RNA in S. typh-
imurium, which is complementary to mgtCBR mRNA, specifies 
the MgtC protein. The AmgR sRNA plays an essential role in 
survival of Salmonella within macrophages and in its virulence 
in mice and is required for replication in a low Mg2+ environment 
(52). Surprisingly, transcription of mgtCBR mRNA and AmgR 
sRNA is controlled by the two-component regulatory system 
PhoP/PhoQ. In detail, when PhoQ senses decrease level of Mg2+ 
in cytoplasm, it phosphorylates PhoP initiating transcription of 
mgtCBR mRNA by direct binding with mgtC and amgR promot-
ers. As MgtB and MgtC protein levels are decreased by long RNA 
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regulatory elements, FtsH protease promotes degradation of the 
MgtR binding to the MgtC protiens. Consequently, AmgR acts 
as a timing device for sense-encoded MgtC protein, which was 
shown to diminish virulence in mice (52). Recently, regulatory 
sRNAs have been identified in Mycobacterium that act in patho-
genesis by regulating the target gene Rv0485 that participates in 
mediation of virulence in mice (53). These studies suggest that 
intracellular pathogens utilize sRNA-based strategies to establish 
productive intracellular infection within host cells.
sRNAs iN MODULATiON OF iNNATe AND 
ADAPTive iMMUNe ReSPONSe
Intracellular pathogens have developed well-organized strate-
gies to cope and interfere with host innate immune mechanisms 
that ultimately facilitate establishment of an environment 
favorable for an effective, long-lasting, adaptive immune 
response (54). The mammalian innate immune response mech-
anism provides first line of defense against invading bacterial 
pathogens. The recognition of molecules typical of a microbe 
pathogen-associated molecular pattern is obtained via pattern-
recognition receptors (PRR) through TLRs that are expressed at 
high levels on DC and macrophages. The TLRs transmit signals 
via MyD88 to activate the NF-κB, MAPKs, and IRF signaling 
pathways to initiate microbial clearance (54). Study of a class 
of sRNAs designated miRNAs, typically 20–22 nt in length, has 
greatly expanded our understanding of mechanisms involved 
in gene expression through posttranscription and translation 
regulation of protein coding genes. miRNAs play pivotal roles 
in modulation of innate as well as in adaptive immune response 
mechanisms (55).
Salmonella
At the initial stages of infection, innate immune response 
mechanisms effectively control the replication and survival of 
Salmonella. In vitro studies indicate that Salmonella modulates 
miRNAs in both epithelial cells and macrophages. Key host 
miRNAs, such as miR-155 and miR-146, are upregulated in 
immune cells in response to intracellular bacterial pathogens, 
apparently co-induced during physiological processes stimulated 
by lipopolysaccharides to repress TLR-mediated recognition of 
bacterial molecules and NF-κB activity (56). Modulation of miR-
146a/b, miR-155, and miR-21 were first reported in Salmonella 
infection, with NF-κB-dependent miRNAs significantly induced 
upon infection in mouse macrophages (57, 58). miRNAs are 
usually triggered in response to sense extracellular stimulus. This 
phenomenon was observed in Salmonella mutant strains defec-
tive in cell invasion (ΔSPI-1) and replication (ΔSPI-2), as well 
as in human monocytes (58, 59). It was subsequently found that 
vaccination of miR-155-null mice with attenuated Salmonella 
vaccine did not confer protection, and mice showed severely 
defective T-cell cytokine production, indicating the complex role 
of miR-155 in innate immune responses to Salmonella (59, 60).
Schulte et al. (56) reported the importance of miR-155 acti-
vation by the sensing bacterial peptidoglycan via cytoplasmic 
NOD2 receptor, suggesting its potential role in innate immune 
response (56). miR-146 function in zebrafish embryos infected 
with S. typhimurium was found to be disrupted by knockdown 
of the TRAF6-MyD88 pathway that mediates transduction of 
TLR signals and cytokine activation (61). miR-146 function 
characterization has revealed that it acts as a negative regulator 
of IRAK1 and TRAF6 expression, which, in turn, affects NF-κB 
signaling pathway (62). miRNA let-7 appears to be a factor in 
the acute innate immune response that participates in the TLR 
signaling pathway via lipopolysaccharide action. In Salmonella 
infection, let-7 was downregulated in a cell-type dependent 
manner in HeLa and murine macrophage cells, suggesting that 
repression of this miRNA family constitutes a common signa-
ture of the infection of phagocytic and non-phagocytic cells 
by Salmonella (57). Zhang and colleagues reported miR-128 
upregulated expression upon Salmonella infection that led to 
reduced secretion of macrophage colony-stimulating factor-
mediated macrophage recruitment, in turn suppressing the host 
immune response mechanisms (63).
Although innate immunity effectively controls replication 
and survival of Salmonella at the initial stages of infection, a 
well-organized adaptive immune response is  also required at 
later stages of chronic infection (54). Salmonella shows the abil-
ity to infect phagocytic and non-phagocytic cells, residing inside 
phagocytic cells in the so-called Salmonella-containing vacuole 
(SCV). Salmonella secretes several virulent SPI-2-encoded 
proteins into the host cytoplasm to facilitate its intracellular 
replication and invasion into host cells through two distinct 
type-III secretion systems (T3SS) (64). Mature DCs may have 
unique tolerogenic properties for initiation and control of adap-
tive immune responses. Salmonella has developed mechanisms 
to counteract the function of DCs, such as subversion of cellular 
trafficking by preventing fusion of the SCV with lysosomes, 
which ultimately facilitates pathogen entry into the host (65). 
Additionally, MHC-I and MHC-II molecules expressed on the 
surface of DCs show elevated numbers of bacterial-derived anti-
gens that facilitate activation of T cells, resulting in enhanced host 
adaptive immune response (66). The B cell intrinsic requirement 
of miR-155 is essential for IgG1 antibody production in response 
to thymus-dependent and -independent antigens, following vac-
cination with attenuated Salmonella (67).
Rodriguez et  al. reported bic/miR-155-deficient mice show 
diminished adaptive immune response against S. typhimurium 
after intravenous immunization that failed to establish strong 
adaptive immunity, likely due to defective antigen presentation 
as well as impaired B and T cell functioning by DCs (60). In 
addition to miR-146 and miR-155, miR-21, miR-23b, miR-27a, 
miR-24, miR-222, and miR-29 showed upregulation upon 
Salmonella infection in human monocytes. The upregulated 
miRNA shows that monocytes differentiation is involved in 
modulation of the TGF-β signaling pathway to counteract host 
defense mechanisms (58).
The miRNA let-7 family members directly target major immu-
nomodulatory cytokines IL-6 and IL-10, and their downregula-
tion results in increased expression of both cytokines in response 
to Salmonella infection (68). miR-21, miR-146a, and miR-155 
show strong induction of NF-κB, leading to decreased regulation 
of B cell and T cell proliferation in murine macrophages upon 
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Salmonella infection (69). These findings suggest that Salmonella 
uses miRNA as a strategy to modulate TLR-NF-κB signaling 
pathways as well as to counteract the function of DCs to subvert 
its cellular trafficking, and miRNAs play a significant role in the 
interaction of innate and adaptive immune mechanisms.
Mycobacterium
Recently, several studies have highlighted the role of miRNAs 
in mycobacterial infection (70). Mycobacterium also modulates 
miRNAs associated with signaling pathways, which enhances 
its survival in the host. miR-155 was found to be upregulated 
in Mycobacterium infection, resulting in increased apoptosis of 
infected cells by the involvement of the TLR2 and NF-κB signaling 
pathways (71). Downregulation of miR-155 result in decreased 
TNF-α production in response to lipomannan, a component of the 
bacterial cell wall, was reported in human macrophages, affecting 
the TLR-MAPK/Akt signaling pathway (72). In addition, MiR-155 
is involved in regulation of autophagy-mediated mycobacterial 
elimination by the repression of the negative regulator Rheb (73). 
miR-142-3p participates in an effective strategy in mycobacterial 
infection to control early events of phagolysosome biogenesis 
via targeting the N-Wasp and actin-binding protein (74). On the 
other hand, down regulation of miR-142-3p negatively regulates 
the production of NF-κB, TNF-α, and IL-6 in macrophages upon 
Mycobacterium bovis infection, resulting in the activation of the 
NF-κB pathway via the de-repression of the target IRAK1 (75). 
miR-124 has been found to serve as a potent modulator of the 
immune response in an M. bovis BCG-infected macrophage cell 
line (Raw 264.7) by targeting components of the TLR signaling 
pathway including MyD88, TLR6, TRAF6, and TNF-α (76).
miR-146a modulates the inflammatory response upon 
Mycobacterium infection in Raw 264.7 cells by targeting IRAK1 
and TRAF6, resulting in remarkably reduced translation of 
IL-6, IL-1β, and TNF-α (77). Kumar and colleagues reported 
that Mycobacterium tuberculosis down regulates the expression 
of miRNA let-7f, which targets mRNA of A20, an inhibitor of 
NF-κB. Significantly, the downregulation of let-7f is accompa-
nied by concomitant upregulation of A20 in mice infected with 
M. tuberculosis (78).
miR-21 was found to induce inhibition of IL-12 produc-
tion in a NF-κB-dependent manner in DCs and T-cells upon 
Mycobacterium infection, and thus suppress host Th1 responses 
(79). Interestingly, miR-21 upregulation promotes DCs apoptosis 
by targeting Bcl-2 in Mycobacterium-infected cells (80). miR-99b 
upregulation has been observed to stimulate the production 
of proinflammatory cytokines such as IL-6, IL-12, IL-1β, and 
TNF-α in macrophages and DCs upon Mycobacterium infection. 
Inhibition of TNF-α production is a key strategy of Mycobacterium 
to promote growth within DCs that, in turn, facilitates evasion of 
host adaptive immune response mechanisms (81). Transfection 
of T cells with miR-144 precursor has demonstrated that miR-
144 possibly regulates antituberculosis immunity by inhibition 
of IFN-γ and TNF-α production and T cell proliferation (82). 
Wang et al. (83) reported that miR-223 and miR-424 promotes 
monocyte differentiation and subsequently downregulates the 
expression of transcription factor NFI-A78. The downregulation 
of miRNAs involved in disorder proportions of T cells and B cells 
in active tuberculosis patients (83). Collectively, these finding 
indicates that Mycobacterium use miRNA-based strategies for 
completion of intracellular replication that, in turn, facilitates 
evasion of the immune response.
Brucella
We studied the expression of miRNAs expression in Brucella 
melitensis-infected RAW 264 macrophages cells and found sev-
eral miRNAs such as miR-let-7b, miR-93, miR-92a, miR-181b, 
and miR-1981, differentially expressed compared to mock-
infected cells, and purposed that these miRNAs are involved in 
regulation of autophagy, apoptosis, innate and adaptive immune 
response mechanisms (Figure 3) (84). Liu et al. (85) reported 
that the downregulation of miR-125b-5p during B. abortus 
infection enhances the expression of the A20 protein, thereby 
inhibiting NF-κB activation and facilitating bacterial intracel-
lular survival (85).
APPROACHeS TO iDeNTiFY BACTeRiAL 
sRNAs
Now that a number of actively transcribed sRNAs have been 
identified in intracellular bacteria, further research should focus 
on the determination of their functions and their specific targets. 
TargetRNA2 was the first webserver specifically designed for iden-
tification of bacterial sRNA target which determine sRNA–target 
interactions through the straight forward hybridization model. It 
determines the seed region between two putative sRNA targets 
which is composed of very small short series of consecutive base 
(86). IntaRNA is also used to identify sRNA targets which work 
on the principle of hybridization energy between base pairings of 
sRNA–target interactions to the hybridization energy of interact-
ing regions being unpaired in intramolecular structures. Further, 
it conform the seed regions more efficiently as compared all other 
available webtools (87). Target prediction could also be used in 
conjunction with experimental genome-wide approaches, such 
as transcriptional profiling (88). Comparison of the transcrip-
tion profile of a mutant strain or an over-expresser strain to the 
wild-type strain can highlight putative targets (9). Comparison 
of the sRNA deletion mutant, the over-expresser strain and the 
wild-type strain by SDS-PAGE and Coomassie staining may be 
sufficient to suggest a putative target (89). The proteomic stud-
ies could be undertaken or more direct approaches, such as the 
streptavidin-binding aptamer tag described above could be used 
(90). Said et al. (91) have performed a systematic analysis for the 
use of different aptamers and configurations to identify protein 
targets of sRNA. Further, we need to establish more accurate 
identification methods for the bacterial sRNA prediction.
SUMMARY AND PeRSPeCTiveS
Recent advancements in research have revealed diverse 
functions, wide distribution, and high variability of sRNAs 
and described their crucial role in biological processes, such 
FiGURe 3 | Overview of modulation of host miRNAs by intracellular bacterial pathogens. The representative figure of modulation of host miRNAs by 
intracellular bacterial pathogens, Salmonella (Gram negative, intracellular), Mycobacteria (intracellular), and Brucella (Gram negative, intracellular).
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as infectivity and virulence of intracellular bacteria, stress 
adaptation, and environmental sensing, as well as in modula-
tion of innate and adaptive immune response mechanisms. 
Intracellular bacteria are divided in two classes: vacu-
olar intracellular bacteria, such as Salmonella, Mycobacterium, 
Legionella, Brucella, and Coxiella, which survive and replicate 
either by avoiding vacuole–lysosome fusion or by altering 
the phagolysosome environment; and cytosolic intracellular 
bacteria, including Francisella, Shigella, Listeria, Burkholderia, 
and Rickettsia, which usually escape to proliferate within the 
cytosol of host cell. Infection is a multidimensional complex 
event, with host cells having developed immune mechanisms 
to counteract invading intracellular pathogens via lysosomal 
degradation to maintain a balance between host resistance 
and bacterial virulence. Intracellular pathogens have evolved 
several sRNA-based strategies to survive and replicate within 
phagocytic cells and to manipulate the host-cell machinery for 
their own benefit. Upon internalization in host cells, the patho-
genic bacteria are usually surrounded by a membrane-bound 
vacuole that protects against proteolytic degradation. Bacterial 
regulatory sRNAs operate at all levels of gene regulation to 
modulate translation, transcription, DNA maintenance or 
silencing, and mRNA stability. They use different mechanisms 
to perform regulatory functions, including changes in RNA 
conformation, base pairing with other RNAs, protein binding, 
and interactions with DNA.
The Csr-type system is the most common posttranscriptional 
regulator network in intracellular bacteria which participates 
with type IVB secretion system to modulate the ER–Golgi vesic-
ular trafficking highlighting the involvement of sRNA-binding 
protein in survival and replication of intracellular pathogens. 
The effector proteins, VipA, RalF, and YlfA, have been linked 
directly in vesicular trafficking to affect the host-cell activity. 
Additionally, sRNA, RsmY and RsmZ, in Legionella, RybB sRNA 
in Salmonella, and sRNA AbcR in Brucella regulate the expres-
sion of effector protein for survival and intracellular replication 
in macrophages.
At the initial stage of infectious pathogenesis, intracellular 
pathogens modulate the immune response mechanism of host 
to quickly translocate through the mucosal immune barrier and 
are endocytosed by mucosal macrophages and DCs. Intracellular 
pathogens infect the host-cell machinery by targeting IRAK1 
and TRAF6 to limit PRRs which, in turn, affects the TLR/NF-κB 
signaling cascade. Inhibition of antigen presentation to T cells is 
a further strategy of intracellular bacteria to dampen innate and 
adaptive immune mechanisms. They have the ability to hinder 
activation of DCs to subvert the immune response mechanism 
by averting function of T-cells and secreting IL-12 to establish a 
strong Th1 immune response.
Additionally, inhibition of TNF-α production and modula-
tion of MHC-I and MHC-II expression is a key strategy of intra-
cellular pathogen to promote growth within DCs that, in turn, 
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favors cytokine regulation to facilitate evasion of host adaptive 
immune response mechanisms. Although numerous strategies 
employed by bacterial sRNAs have been reported, there are 
many mysteries that are still veiled, including how are sRNAs 
involved in modulation of innate immune signaling? What is 
the role of sRNAs in regulation of apoptosis and autophagy 
mechanisms? To date, nothing is known about the role of sRNA 
interfering with innate and adaptive immune mechanism of 
Brucella and Legionella and it will be an open question for the 
next few years. In-depth identification of novel immune eva-
sion strategies employed by bacterial sRNAs will facilitate our 
understanding of pathogenesis and designing of novel effective 
therapeutic approaches to combat diseases caused by intracel-
lular pathogens.
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